Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Bosch

Showing results (91-100 of 170) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|May 26, 2010
Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab eraGonzalo Gutiérrez-García, Lluis Colomo, Neus Villamor, et al.
International Journal of Laboratory Hematology|February 22, 2021
Reduced expansion of CD94/NKG2C<sup>+</sup> NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletionsAnna Puiggros, Gonzalo Blanco, Aura Muntasell, et al.
Ejhaem|November 29, 2023
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphomaMarta Ligero, Marc Simó, Cecilia Carpio, et al.
Medicina Clinica|January 11, 2025
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)Ángeles Medina, Ana Muntañola, Marta Crespo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid LeukemiaOlga Salamero, Pau Montesinos, Christophe Willekens, et al.
Leukemia|May 13, 2020
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapyJuan C Nieto, Elisa Roldán, Isabel Jiménez, et al.
Oncoimmunology|June 7, 2018
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLLGonzalo Blanco, Anna Vardi, Anna Puiggros, et al.
British Journal of Haematology|February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN studyStephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
Leukemia & Lymphoma|February 7, 2022
Variant t(11;22)(q13;q11.2) with <i>IGL</i> involvement in mantle cell lymphomaAlba Cabirta, Gloria Hidalgo-Gómez, Ana Marín-Niebla, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 12, 2020
Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?Isabel González-Gascón-Y-Marín, Carolina Muñoz-Novas, Iñigo Figueroa, et al.
Pageof 17

Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|May 26, 2010
Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab eraGonzalo Gutiérrez-García, Lluis Colomo, Neus Villamor, et al.
International Journal of Laboratory Hematology|February 22, 2021
Reduced expansion of CD94/NKG2C<sup>+</sup> NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletionsAnna Puiggros, Gonzalo Blanco, Aura Muntasell, et al.
Ejhaem|November 29, 2023
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphomaMarta Ligero, Marc Simó, Cecilia Carpio, et al.
Medicina Clinica|January 11, 2025
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)Ángeles Medina, Ana Muntañola, Marta Crespo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid LeukemiaOlga Salamero, Pau Montesinos, Christophe Willekens, et al.
Leukemia|May 13, 2020
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapyJuan C Nieto, Elisa Roldán, Isabel Jiménez, et al.
Oncoimmunology|June 7, 2018
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLLGonzalo Blanco, Anna Vardi, Anna Puiggros, et al.
British Journal of Haematology|February 19, 2021
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN studyStephan Stilgenbauer, Francesc Bosch, Osman Ilhan, et al.
Leukemia & Lymphoma|February 7, 2022
Variant t(11;22)(q13;q11.2) with <i>IGL</i> involvement in mantle cell lymphomaAlba Cabirta, Gloria Hidalgo-Gómez, Ana Marín-Niebla, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 12, 2020
Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?Isabel González-Gascón-Y-Marín, Carolina Muñoz-Novas, Iñigo Figueroa, et al.
Pageof 17